BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21976476)

  • 1. Effects of combination therapy with peritoneal dialysis and hemodialysis on left ventricular hypertrophy.
    Tanaka M; Mise N; Nakajima H; Uchida L; Ishimoto Y; Kotera N; Tanaka S; Kurita N; Sugimoto T
    Perit Dial Int; 2011; 31(5):598-600. PubMed ID: 21976476
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetes mellitus and dialysis.
    Stein G; Fünfstück R; Schiel R
    Minerva Urol Nefrol; 2004 Sep; 56(3):289-303. PubMed ID: 15467507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of seven years' home peritoneal dialysis.
    Mion C
    Proc Eur Dial Transplant Assoc; 1981; 18():91-108. PubMed ID: 7330003
    [No Abstract]   [Full Text] [Related]  

  • 4. High-intensity hemodialysis: the wave of the future?
    Ing TS; Ronco C; Blagg CR
    Int J Artif Organs; 2008 Mar; 31(3):201-12. PubMed ID: 18373313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal replacement therapy utilizing hemodialysis and peritoneal dialysis.
    Paganini EP; Vidt DG
    Urol Clin North Am; 1983 May; 10(2):347-67. PubMed ID: 6344391
    [No Abstract]   [Full Text] [Related]  

  • 6. Residual renal function in patients on peritoneal dialysis: effect of peritonitis episodes.
    Rivera-Gorrin M; Teruel-Briones JL; Rodríguez-Mendiola N; Díaz-Domínguez M; Ruiz-Roso G; Quereda-Rodríguez-Navarro C
    Nefrologia; 2014 Nov; 34(6):802-4. PubMed ID: 25415582
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of dialysis modality on the appropriateness of left ventricular mass in patients with end-stage renal disease.
    Paneni F; Gregori M; Ciavarella GM; Sciarretta S; Tocci G; Palano F; Domenici A; Punzo G; De Biase L; Menè P; Volpe M
    Int J Cardiol; 2011 Jun; 149(2):250-252. PubMed ID: 21392833
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of hemodialysis therapy in a case with factor XIII deficiency.
    Hiwatashi A; Usui JI; Sato C; Hasegawa Y; Yamagata K
    Clin Exp Nephrol; 2011 Oct; 15(5):791-792. PubMed ID: 21710188
    [No Abstract]   [Full Text] [Related]  

  • 9. Differences in initial treatment modality for end-stage renal disease among glomerulonephritis subtypes in the USA.
    O'Shaughnessy MM; Montez-Rath ME; Lafayette RA; Winkelmayer WC
    Nephrol Dial Transplant; 2016 Feb; 31(2):290-8. PubMed ID: 26610594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Causes of chronic renal failure and clinical status of patients during initiation of hemodialysis therapy in upper Silesian region].
    Zarzecki M; Chudek J; Kułach A; Hołowiecka A; Kania M; Kopeć P; Kukla M; Machała L; Pyda M; Rozmus W; Szpak S; Wiecek A
    Wiad Lek; 2004; 57(3-4):145-50. PubMed ID: 15307522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indications for dialysis and transplantation in end-stage renal disease.
    van Ypersele de Strihou C; Pirson Y
    Contrib Nephrol; 1989; 71():104-10. PubMed ID: 2680259
    [No Abstract]   [Full Text] [Related]  

  • 12. The management of terminal renal failure in diabetic patients by regular dialysis therapy.
    White N; Snowden SA; Parsons V; Sheldon J; Bewick M
    Nephron; 1973; 11(5):261-75. PubMed ID: 4753518
    [No Abstract]   [Full Text] [Related]  

  • 13. The prevalence of left ventricular hypertrophy in Chinese hemodialysis patients is higher than that in peritoneal dialysis patients.
    Tian JP; Wang T; Wang H; Cheng LT; Tian XK; Lindholm B; Axelsson J; Du FH
    Ren Fail; 2008; 30(4):391-400. PubMed ID: 18569912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving outcomes for diabetic patients on dialysis-an introduction.
    Williams ME
    Semin Dial; 2010; 23(2):127-8. PubMed ID: 20525105
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin receptor antagonist regresses left ventricular hypertrophy associated with diabetic nephropathy in dialysis patients.
    Kanno Y; Kaneko K; Kaneko M; Kotaki S; Mimura T; Takane H; Suzuki H
    J Cardiovasc Pharmacol; 2004 Mar; 43(3):380-6. PubMed ID: 15076221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infants Requiring Maintenance Dialysis: Outcomes of Hemodialysis and Peritoneal Dialysis.
    Vidal E; van Stralen KJ; Chesnaye NC; Bonthuis M; Holmberg C; Zurowska A; Trivelli A; Da Silva JEE; Herthelius M; Adams B; Bjerre A; Jankauskiene A; Miteva P; Emirova K; Bayazit AK; Mache CJ; Sánchez-Moreno A; Harambat J; Groothoff JW; Jager KJ; Schaefer F; Verrina E;
    Am J Kidney Dis; 2017 May; 69(5):617-625. PubMed ID: 27955924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal dialysis as a treatment option in autosomal dominant polycystic kidney disease.
    Jankowska M; Chmielewski M; Lichodziejewska-Niemierko M; Jagodziński P; Rutkowski B
    Int Urol Nephrol; 2015 Oct; 47(10):1739-44. PubMed ID: 26282281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal dialysis for patients with diabetes and end-stage renal disease: sorting out the biases?
    Finkelstein FO; Smith JD
    ASAIO J; 1996; 42(1):1-3. PubMed ID: 8808447
    [No Abstract]   [Full Text] [Related]  

  • 19. The changes in cardiac dimensions and function in patients with end stage renal disease undergoing hemodialysis.
    Lee DW; Kim YB; An SJ; Jung YS; Kwak IS; Shin YW; Rha HY
    Korean J Intern Med; 2002 Jun; 17(2):107-13. PubMed ID: 12164087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic nephropathy in hemodialysis patients in Constantine, Algeria.
    Bouhabel A; Saadi N; Bendjeddou J; Laib Z; Hannache K; Aberkane A
    Saudi J Kidney Dis Transpl; 2015 Jan; 26(1):139-40. PubMed ID: 25579737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.